Skip to main content

Table 1 Patient demographics

From: Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study

  Age
(years)
Sex Education
(years)
ApoE4 carrier Comorbidities Medications
Case 1 58 F 6 Yes None Rivastigmine 18 mg, Choline alfoscerate 800 mg, Lexapro 5 mg
Case 2 80 F 9 Yes None Rivastigmine 18 mg, Choline alfoscerate 800 mg, Lexapro 5 mg
Case 3 55 F 12 Yes Myasthenia gravis Rivastigmine 27 mg, Memantine 5 mg, Lexapro 5 mg, Prednisolone 5 mg, Tacrolimus 3 mg
Case 4 85 F 12 Yes Hypertension, osteoporosis Donepezil 10 mg, Candesartan 16 mg, Amlodipine 5 mg, Calcium 500 mg, Cholecalciferol 1000 IU
Case 5 75 M 12 No None Galantamine 16 mg
Mean (SD) 70.6 (13.5)   10.2 (2.7)    
  1. SD standard deviation